Stomach cancer burden in Central and South America

Cancer Epidemiology

Volumn 44, Issue , 2016, Pages S62-S73

  Sierra, Monica S ^a   Cueva, Patricia ^b   Bravo, Luis Eduardo ^c   Forman, David ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b Hospital Oncológico SOLCA Núcleo de Quito   (Ecuador)

^c UNIVERSIDAD DEL VALLE   (Colombia)

Author keywords

Cardia; Central and South America; Neoplasm; Non cardia; Stomach; Trends

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER REGISTRY; CENTRAL AMERICA; FEMALE; GENDER; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RATE; PRIORITY JOURNAL; SOUTH AMERICA; STOMACH CANCER;

EID: 84991696921     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2016.03.008     Document Type: Article

References (88)

1. [1] Jemal, A., Center, M.M., DeSantis, C., Ward, E.M., Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol. Biomarker Prev. 19:8 (2010), 1893–1907, 10.1158/1055-9965.EPI-10-0437.
2. [2] Bertuccio, P., Chatenoud, L., Levi, F., Praud, D., Ferlay, J., Negri, E., et al. Recent patterns in gastric cancer: a global overview. Int. J. Cancer 125:3 (2009), 666–673, 10.1002/ijc.24290.
3. [3] D. Forman, M.S. Sierra. The current and projected global burden of gastric cancer. Helicobacter pylori Eradication as a Strategy for Preventing Gastric Cancer. IARC Helicobacter pylori Working Group. Lyon, France: International Agency for Research on Cancer (IARC Working Group Reports, No. 8) (2014) 5, 15.
4. [4] Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. 2014, International Agency for Research on Cancer Available from: URL: http://globocan.iarc.fr.
5. [5] Carneiro, F., Stomach cancer. Stewart, B., Wild, C., (eds.) World Cancer Report 2014, 2014, International Agency for Research on Cancer, Lyon, France, 383–391.
6. [6] Cancer Incidence in Five Continents, Vol. X. International Agency for Research on Cancer 2014 Available from: URL: http://ci5.iarc.fr.
7. [7] Torres, J., Correa, P., Ferreccio, C., Hernandez-Suarez, G., Herrero, R., Cavazza-Porro, M., et al. Gastric cancer incidence and mortality is associated with altitude in the mountainous regions of Pacific Latin America. Cancer Causes Control 24:2 (2013), 249–256, 10.1007/s10552-012-0114-8.
8. [8] de Martel, C., Forman, D., Plummer, M., Gastric cancer: epidemiology and risk factors. Gastroenterol. Clin. North Am. 42:2 (2013), 219–240, 10.1016/j.gtc.2013.01.003.
9. [9] Forman, D., Burley, V.J., Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract. Res. Clin. Gastroenterol. 20:4 (2006), 633–649, 10.1016/j.bpg.2006.04.008.
10. [10] Palli, D., Epidemiology of gastric cancer: an evaluation of available evidence. J. Gastroenterol. 35:S12 (2000), 84–89.
11. [11] Correa, P., Piazuelo, M.B., Camargo, M.C., The future of gastric cancer prevention. Gastric Cancer 7:1 (2004), 9–16, 10.1007/s10120-003-0265-0.
12. [12] Ferro, A., Peleteiro, B., Malvezzi, M., Bosetti, C., Bertuccio, P., Levi, F., et al. Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype. Eur. J. Cancer 50:7 (2014), 1330–1344, 10.1016/j.ejca.2014.01.029.
13. [13] Bosman, F.T., Carneiro, F., Hruban, R.H., Theise, N.D., WHO Classification of Tumours of the Digestive System. fourth ed., 2010, IARC WHO Classification of Tumours, Lyon.
14. [14] Mukaisho, K., Nakayama, T., Hagiwara, T., Hattori, T., Sugihara, H., Two distinct etiologies of gastric cardia adenocarcinoma: interactions among pH, Helicobacter pylori, and bile acids. Front. Microbiol., 6, 2015, 412, 10.3389/fmicb.2015.00412.
15. [15] Wilfong, J., Zalupski, M.M., Gastric cancer. Tod, R.F. III, Conney, K.A., Hayes, T.G., Mims, M.P., Worden, F.P., (eds.) Tumor Review Board: Guideline and Case Reviews in Oncology, second ed., 2015, 85–94.
16. [16] Parsonnet, J., Vandersteen, D., Goates, J., Sibley, R.K., Pritikin, J., Chang, Y., Helicobacter pylori Infection in intestinal- and diffuse-type gastric adenocarcinomas. J. Natl. Cancer Inst. 83:9 (1991), 640–643.
17. [17] Colquhoun, A., Arnold, M., Ferlay, J., Goodman, K.J., Forman, D., Soerjomataram, I., Global patterns of cardia and non-cardia gastric cancer incidence in 2012. Gut, 2015, 10.1136/gutjnl-2014-308915.
18. [18] Plummer, M., Franceschi, S., Vignat, J., Forman, D., de Martel, C., Global burden of gastric cancer attributable to pylori. Int. J. Cancer 136:2 (2015), 487–490, 10.1002/ijc.28999.
19. [19] Gonzaga Coelho, L., Helicobacter pylori in South America. Miklos, B.G., (eds.) Helicobacter Pylori: A Worldwide Perspective 2014, 2014, Bentham Science Publishers, Oak Park, IL, USA.
20. [20] Coelho, L.G., Leon-Barua, R., Quigley, E.M., Latin-American consensus conference on Helicobacter pylori infection. Latin-American National Gastroenterological Societies affiliated with the Inter-American Association of Gastroenterology (AIGE). Helicobacter pylori, 2000, 2688–2691, 10.1111/j.1572-0241.2000.03174.x.
21. [21] Correa, P., Piazuelo, M.B., Helicobacter pylori infection and gastric adenocarcinoma. US Gastroenterol. Hepatol. Rev. 7:1 (2011), 59–64.
22. [22] Yepez, M.C., Bravo, L.E., HidalgoTroya, A., Jurado, D.M., Bravo, L.M., Cancer incidence and mortality in the municipality of Pasto, 1998–2007. Colombia Med. 43:4 (2012), 256–266.
23. [23] Bravo, L.E., Collazos, T., Collazos, P., Garcia, L.S., Correa, P., Trends of cancer incidence and mortality in Cali, Colombia, 50 years experience. Colombia Med. 43:4 (2012), 246–255.
24. [24] Chatenoud, L., Bertuccio, P., Bosetti, C., Malvezzi, M., Levi, F., Negri, E., et al. Trends in mortality from major cancers in the Americas: 1980–2010. Ann. Oncol. 25:9 (2014), 1843–1853, 10.1093/annonc/mdu206.
25. [25] Chatenoud, L., Bertuccio, P., Bosetti, C., Levi, F., Curado, M.P., Malvezzi, M., et al. Trends in cancer mortality in Brazil, 1980–2004. Eur. J. Cancer Prev. 19:2 (2010), 79–86, 10.1097/CEJ.0b013e32833233be.
26. [26] Bosetti, C., Rodriguez, T., Chatenoud, L., Bertuccio, P., Levi, F., Negri, E., et al. Trends in cancer mortality in Mexico, 1981–2007. Eur. J. Cancer Prev. 20:5 (2011), 355–363, 10.1097/CEJ.0b013e32834653c9.
27. [27] Malvezzi, M., Bosetti, C., Chatenoud, L., Rodriguez, T., Levi, F., Negri, E., et al. Trends in cancer mortality in Mexico, 1970–1999. Ann. Oncol. 15:11 (2004), 1712–1718, 10.1093/annonc/mdh424.
28. [28] Politis, M., Higuera, G., Chang, L.R., Gomez, B., Bares, J., Motta, J., Trend analysis of cancer mortality and incidence in Panama, using joinpoint regression analysis. Medicine, 94(24), 2015, e970, 10.1097/MD.0000000000000970.
29. [29] Mortality database. World Health Organization (2014). Available from: URL: http://www.who.int/healthinfo/statistics/mortality_rawdata/en/index.html.
30. [30] Bonequi, P., Meneses-Gonzalez, F., Correa, P., Rabkin, C., Camargo, M.C., Risk factors for gastric cancer in Latin America: a meta-analysis. Cancer Causes Control 24:2 (2013), 217–231, 10.1007/s10552-012-0110-z.
31. [31] Segi, M., Kurihara, M., Daigaku, T., Trends in Cancer Mortality for Selected Sites in 24 Countries 1950–1959. 1963, Department of Public Health, Tohoku University School of Medicine.
32. [32] Doll, R., Payne, P., Waterhouse, J.A.H., Cancer Incidence in Five Continents, vol. I, 1966, Union Internationale Contre le Cancer, Geneva.
33. [33] Esteve, J., Benhamou, E., Raymond, L., Statistical methods in cancer research. Descriptive Epidemiology, vol. IV, 1994, IARC Scientific Publication 128:1–302.
34. [34] Stata data analysis and statistical Software Version 12.1. StataCorp, L.P. (2011).
35. [35] International Classification of Diseases for Oncology, Third Edition, First Revision. Geneva: World Health Organization 2013 Available from: URL: http://codes.iarc.fr/.
36. [36] Chang, E.T., Gomez, S.L., Fish, K., Schupp, C.W., Parsonnet, J., DeRouen, M.C., et al. Gastric cancer incidence among Hispanics in California: patterns by time, nativity, and neighborhood characteristics. Cancer Epidemiol. Biomarker Prev. 21:5 (2012), 709–719, 10.1158/1055-9965.EPI-11-1208.
37. [37] Anderson, W.F., Camargo, M., Fraumeni, J.F., Correa, P., Rosenberg, P.S., Rabkin, C.S., Age-specific trends in incidence of noncardia gastric cancer in us adults. JAMA 303:17 (2010), 1723–1728, 10.1001/jama.2010.496.
38. [38] Corral, J.E., Delgado Hurtado, J.J., Dominguez, R.L., Valdez de Cuellar, M., Balmore Cruz, C., Morgan, D.R., The descriptive epidemiology of gastric cancer in Central America and comparison with United States Hispanic populations. J. Gastrointest. Cancer 46:1 (2015), 21–28, 10.1007/s12029-014-9672-1.
39. [39] Heise, K., Bertran, E., Andia, M.E., Ferreccio, C., Incidence and survival of stomach cancer in a high-risk population of Chile. World. J. Gastroenterol., 15(15), 2009, 1854, 10.3748/wjg.15.1854.
40. [40] Pilco, C., Payet, M., Caceres, G., Cancer gastrico en Lima metropolitana. Rev. Gastroenterol. Peru 26:4 (2006), 377–385.
41. [41] Pineros, M., Ferlay, J., Murill, R., Cancer incidence estimates at the national and district levels in Colombia. Salud Publ. Mex. 48:6 (2006), 455–465, 10.1590/S0036-36342006000600003.
42. [42] Loria, D., Lence Anta, J.J., Guerra Yi, M.E., Galan Alvarez, Y., Barrios Herrera, E., Alonso Barbeito, R., et al. Tendencia de la mortalidad por cancer en Argentina, Cuba y Uruguay en un periodo de 15 años. Rev. Cub. Salud Publ. 36:2 (2010), 115–125.
43. [43] Bosetti, C., Malvezzi, M., Chatenoud, L., Negri, E., Levi, F., La Vecchia, C., Trends in cancer mortality in the Americas, 1970–2000. Ann. Oncol. 16:3 (2005), 489–511, 10.1093/annonc/mdi086.
44. [44] Pineros, M., Hernandez, G., Bray, F., Increasing mortality rates of common malignancies in Colombia. Cancer 101:10 (2004), 2285–2292, 10.1002/cncr.20607.
45. [45] Torres, J., Lopez, L., Lazcano, E., Camorlinga, M., Flores, L., Munoz, O., Trends in Helicobacter pylori infection and gastric cancer in Mexico. Cancer Epidemiol. Biomarker Prev. 14:8 (2005), 1874–1877, 10.1158/1055-9965.EPI-05-0113.
46. [46] Al-Refaie, W.B., Tseng, J.F., Gay, G., Patel-Parekh, L., Mansfield, P.F., Pisters, P.W.T., et al. The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma. Cancer 113:3 (2008), 461–469, 10.1002/cncr.23572.
47. [47] Kim, J., Sun, C.L., Mailey, B., Prendergast, C., Artinyan, A., Bhatia, S., et al. Race and ethnicity correlate with survival in patients with gastric adenocarcinoma. Ann. Oncol. 21:1 (2010), 152–160, 10.1093/annonc/mdp290.
48. [48] Sipponen, P., Correa, P., Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer 5:4 (2002), 0213–0219, 10.1007/s101200200037.
49. [49] Song, M., Kang, D., Yang, J., Choi, J.Y., Sung, H., Lee, Y., et al. Age and sex interactions in gastric cancer incidence and mortality trends in Korea. Gastric Cancer 18:3 (2015), 580–589, 10.1007/s10120-014-0411-x.
50. [50] Camargo, M.C., Goto, Y., Zabaleta, J., Morgan, D.R., Correa, P., Rabkin, C.S., Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis. Cancer Epidemiol. Biomarker Prev., 2011, 1–19, 10.1158/1055-9965.epi-11-0834.
51. [51] Derakhshan, M.H., Liptrot, S., Paul, J., Brown, I.L., Morrison, D., McColl, K.E.L., Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females. Gut 58:1 (2009), 16–23, 10.1136/gut.2008.161331.
52. [52] Cogliano, V.J., Baan, R., Straif, K., Grosse, Y., Lauby-Secretan, B., El Ghissassi, F., et al. Preventable exposures associated with human cancers. J. Natl. Cancer Inst. 103:24 (2011), 1827–1839, 10.1093/jnci/djr483.
53. [53] Torres, J., Perez-Perez, G., Goodman, K.J., Atherton, J.C., Gold, B.D., Harris, P.R., et al. A comprehensive review of the natural history of Helicobacter pylori infection in children. Arch. Med. Res. 31:5 (2000), 431–469, 10.1016/S0188-4409(00)00099-0.
54. [54] Sierra, M.S., Hastings, E.V., Fagan-Garcia, K., Colquhoun, A., Goodman, K.G., Epidemiology, transmission and public health implications of Helicobacter pylori infection in Western Countries. Miklos, B.G., (eds.) Helicobacter Pylori: A Worldwide Perspective 2014, 2014, Bentham Science Publishers, Oak Park, IL, USA, 25–79.
55. [55] Ladeiras-Lopes, R., Pereira, A., Nogueira, A., Pinheiro-Torres, T., Pinto, I., Santos-Pereira, R., et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control 19:7 (2008), 689–701, 10.1007/s10552-008-9132-y.
56. [56] Freedman, N.D., Derakhshan, M.H., Abnet, C.C., Schatzkin, A., Hollenbeck, A.R., McColl, K.E.L., Male predominance of upper gastrointestinal adenocarcinoma cannot be explained by differences in tobacco smoking in men versus women. Eur. J. Cancer 46:13 (2010), 2473–2478, 10.1016/j.ejca.2010.05.005.
57. [57] Ezzati, M., Henley, S.J., Lopez, A.D., Thun, M.J., Role of smoking in global and regional cancer epidemiology: current patterns and data needs. Int. J. Cancer 116:6 (2005), 963–971, 10.1002/ijc.21100.
58. [58] Muller, F., Wehbe, L., Smoking and smoking cessation in Latin America: a review of the current situation and available treatments. Int. J. Chron. Obstruct. Pulmon. Dis. 3:2 (2008), 285–293.
59. [59] Global Health Observatory Data Repository. World Health Organization 2014 Available from: URL: http://apps.who.int/gho/data/?theme=main.
60. [60] Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., Ghissassi, F.E., et al. A review of human carcinogens—part B: biological agents. Lancet Oncol. 10:4 (2009), 321–322, 10.1016/S1470-2045(09)70096-8.
61. [61] Wu, H., Rusiecki, J.A., Zhu, K., Potter, J., Devesa, S.S., Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol. Biomarker Prev. 18:7 (2009), 1945–1952, 10.1158/1055-9965.EPI-09-0250.
62. [62] Ford, A.C., Forman, D., Hunt, R.H., Yuan, Y., Moayyedi, P., Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ, 34, 2014, 348, 10.1136/bmj.g3174.
63. [63] Wang, J., Xu, L., Shi, R., Huang, X., Li, S.W.H., Huang, Z., et al. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis. Digestion 83:4 (2011), 253–260, 10.1159/000280318.
64. [64] Camargo, M.C., Garcia, A., Riquelme, A., Otero, W., Camargo, C.A., Hernandez-Garcia, T., et al. The problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin America. Am. J. Gastroenterol. 109:4 (2014), 485–495, 10.1038/ajg.2014.24.
65. [65] Rollan, A., Arab, J.P., Camargo, M.C., Candia, R., Harris, P., Ferreccio, C., et al. Management of Helicobacter pylori infection in latin america: a Delphi technique-based consensus. World J. Gastroenterol. 20:31 (2014), 10969–10983, 10.3748/wjg.v20.i31.10969.
66. [66] Ferreccio, C., The regional status of current or planned gastric cancer prevention strategies in Latin America. Helicobacter Pylori Eradication as Strategy for Preventing Gastric Cancer, 2014, 37.
67. [67] Rosero-Bixby, L., Sierra, R., X-ray screening seems to reduce gastric cancer mortality by half in a community-controlled trial in Costa Rica. Br. J. Cancer 97:7 (2007), 837–843, 10.1038/sj.bjc.6603729.
68. [68] Pisani, P., Oliver, W.E., Parkin, D.M., Alvarez, N., Vivas, J., Case-control study of gastric cancer screening in Venezuela. Br. J. Cancer 69:6 (1994), 1102–1105, 10.1038/bjc.1994.216.
69. [69] Tramacere, I., Pelucchi, C., Bagnardi, V., Rota, M., Scotti, L., Islami, F., et al. A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk. Ann. Oncol. 23:2 (2011), 287–297, 10.1093/annonc/mdr136.
70. [70] Tramacere, I., Negri, E., Pelucchi, C., Bagnardi, V., Rota, M., Scotti, L., et al. A meta-analysis on alcohol drinking and gastric cancer risk. Ann. Oncol. 23:1 (2011), 28–36, 10.1093/annonc/mdr135.
71. [71] Baan, R., Straif, K., Grosse, Y., Secretan, B., El Ghissassi, F., Bouvard, V., et al. Carcinogenicity of alcoholic beverages. Lancet Oncol. 8:4 (2007), 292–293, 10.1016/S1470-2045(07)70099-2.
72. [72] Food, nutrition, physical activity, and the prevention of cancer: a global perspective. World Cancer Research Fund/American Institute for Cancer Research 2007 Available from: URL: http://www.dietandcancerreport.org/cancer_resource_center/downloads/Second_Expert_Report_full.pdf.
73. [73] Bouvard, V., Loomis, D., Guyton, K.Z., Grosse, Y., Ghissassi, F.E., Benbrahim-Tallaa, L., et al. Carcinogenicity of consumption of red and processed meat. Lancet Oncol., 2015, 10.1016/s1470-2045(15)00444-1.
74. [74] Aleman, J.O., Eusebi, L.H., Ricciardiello, L., Patidar, K., Sanyal, A.J., Holt, P.R., Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology 146:2 (2014), 357–373, 10.1053/j.gastro.2013.11.051.
75. [75] Kubo, A., Corley, D.A., Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol. Biomarker Prev. 15:5 (2006), 872–878, 10.1158/1055-9965.EPI-05-0860.
76. [76] Chen, Y., Liu, L., Wang, X., Wang, J., Yan, Z., Cheng, J., et al. Body mass index and risk of gastric cancer: a meta-analysis of a population with more than ten million from 24 prospective studies. Cancer Epidemiol. Biomarker Prev. 22:8 (2013), 1395–1408, 10.1158/1055-9965.EPI-13-0042.
77. [77] Lin, X.J., Wang, C.P., Liu, X.D., Yan, K.K., Li, S., Bao, H.H., et al. Body mass index and risk of gastric cancer: a meta-analysis. Jpn. J. Clin. Oncol., 2014, 2016, hyu082.
78. [78] The Emerging Risk Factors Collaboration, Wormser, D., Angelantonio, E.D., Kaptoge, S., Wood, A.M., Gao, P., et al. Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. Int. J. Epidemiol. 41:5 (2012), 1419–1433, 10.1093/ije/dys086.
79. [79] Wiren, S., Haggstrom, C., Ulmer, H., Manjer, J., Bjorge, T., Nagel, G., et al. Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes Control 25:2 (2014), 151–159, 10.1007/s10552-013-0317-7.
80. [80] Camargo, M.C., Freedman, N.D., Hollenbeck, A.R., Abnet, C.C., Rabkin, C.S., Height, weight, and body mass index associations with gastric cancer subsites. Gastric Cancer 17:3 (2014), 463–468.
81. [81] Camargo, M.C., Rabkin, C.S., Appel, N., Hollenbeck, A.R., Variable association of height with gastric cancer by anatomical subsite. Cancer Causes Control, 26(9), 2015, 1361, 10.1007/s10552-015-0616-2.
82. [82] Camargo, M.C., Murphy, G., Koriyama, C., Pfeiffer, R.M., Kim, W.H., Herrera-Goepfert, R., et al. Determinants of Epstein-barr virus-positive gastric cancer: an international pooled analysis. Br. J. Cancer 105:1 (2011), 38–43, 10.1038/bjc.2011.215.
83. [83] Singh, S., Varayil, J.E., Devanna, S., Murad, M.H., Iyer, P.G., Physical activity is associated with reduced risk of gastric vancer: a systematic review and meta-analysis. Can. Prev. Res. 7:1 (2014), 12–22, 10.1158/1940-6207.CAPR-13-0282.
84. [84] Wang, W.H., Huang, J.Q., Zheng, G.F., Lam, S.K., Karlberg, J., Wong, B.C.-Y., Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J. Natl. Cancer Inst. 95:23 (2003), 1784–1791, 10.1093/jnci/djg106.
85. [85] Yang, P., Zhou, Y., Chen, B., Wan, H.W., Jia, G.Q., Bai, H.L., et al. Aspirin use and the risk of gastric cancer: a meta-analysis. Dig. Dis. Sci. 55:6 (2010), 1533–1539, 10.1007/s10620-009-0915-0.
86. [86] Tian, W., Zhao, Y., Liu, S., Li, X., Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer. Eur. J. Cancer Prev. 19:4 (2010), 288–298, 10.1097/CEJ.0b013e328339648c.
87. [87] Lindblad, M., Ye, W., Lindgren, A., Lagergren, J., Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates. Ann. Surg. 243:4 (2006), 479–485, 10.1097/01.sla.0000205825.34452.43.
88. [88] Corley, D.A., Kubo, A., Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas. J. Natl. Cancer Inst. 96:18 (2004), 1383–1387, 10.1093/jnci/djh265.